Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	104.91
Bid (Size)	104.94 (100)
Ask (Size)	104.99 (500)
Prev. Close	104.91
Today's Range	104.91 - 104.91
52wk Range	38.81 - 104.91
Shares Outstanding	171,948,769
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery

March 24, 2026

As the first quarter of 2026 draws to a close, the global mergers and acquisitions (M&A) market has delivered a paradox that is reshaping the financial landscape. Preliminary data reveals that total...

Via MarketMinute

Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics

March 23, 2026

CHICAGO — In a move that fundamentally reshapes the global diagnostics landscape, Abbott Laboratories (NYSE: ABT) officially completed its $21 billion acquisition of Exact Sciences (NASDAQ: EXAS)...

Via MarketMinute

Performance

YTD	+3.1%	+3.1%
1 Month	+1.5%	+1.5%
3 Month	+3.3%	+3.3%
6 Month	+100.2%	+100.2%
1 Year	+122.8%	+122.8%

More News

EXACT SCIENCES CORP (NASDAQ:EXAS) Shows Strong Technical and Fundamental Momentum ↗

March 04, 2026

Via Chartmill

Clearwater Analytics Stock Lands $37 Million Investment Amid 77% ARR Growth Surge and Pending Buyout ↗

March 22, 2026

Via The Motley Fool

This $19.8 Million Bet on Commvault Comes Amid a 51% Drop. Here’s What Investors Should Know ↗

March 22, 2026

Via The Motley Fool

The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips

March 19, 2026

Via MarketMinute

1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now ↗

March 19, 2026

Via The Motley Fool

Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026

March 17, 2026

From Exact Sciences Corp.

Via Business Wire

1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds

March 17, 2026

Via StockStory

Hedge Fund Beryl Capital Initiated a Position in CSG Systems Worth Over $54 Million. Is the Stock a Buy? ↗

March 11, 2026

Via The Motley Fool

Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks

March 09, 2026

Via MarketMinute

3 Cash-Producing Stocks We Approach with Caution

March 05, 2026

Via StockStory

The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"

March 04, 2026

Via MarketMinute

Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

March 04, 2026

From Exact Sciences Corp.

Via Business Wire

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

March 03, 2026

From Amalgam Rx, Inc.

Via Business Wire

Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time ↗

February 25, 2026

Via The Motley Fool

Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech

February 23, 2026

Via MarketMinute

Exact Sciences Stockholders Approve Acquisition by Abbott

February 20, 2026

From Exact Sciences Corp.

Via Business Wire

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

Via MarketMinute

February 18, 2026

Via StockStory

3 Overrated Stocks That Concern Us

February 15, 2026

Via StockStory

Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results

February 13, 2026

From Exact Sciences Corp.

Via Business Wire

Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever ↗

February 12, 2026

Via The Motley Fool

Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their Shareholders

February 09, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)

February 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?

Yes, Exact Sciences Corporation - Common Stock is publicly traded.

What exchange does Exact Sciences Corporation - Common Stock trade on?

Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Exact Sciences Corporation - Common Stock?

The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market

What is the current price of Exact Sciences Corporation - Common Stock?

The current price of Exact Sciences Corporation - Common Stock is 104.91

When was Exact Sciences Corporation - Common Stock last traded?

The last trade of Exact Sciences Corporation - Common Stock was at 03/20/26 04:00 PM ET

What is the market capitalization of Exact Sciences Corporation - Common Stock?

The market capitalization of Exact Sciences Corporation - Common Stock is 18.04B

How many shares of Exact Sciences Corporation - Common Stock are outstanding?

Exact Sciences Corporation - Common Stock has 18B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.